Intended for healthcare professionals

Letters Hormone replacement therapy and venous thromboembolism

Hormone replacement therapy: changes in prescribing practice

BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l633 (Published 11 February 2019) Cite this as: BMJ 2019;364:l633
  1. Melanie Davies, member,
  2. Haitham Hamoda, chair elect
  3. on behalf of the British Menopause Society Medical Advisory Council
  1. British Menopause Society Medical Advisory Council, British Menopause Society, Spracklen House, Marlow SL7 2QH, UK
  1. haitham.hamoda{at}nhs.net

Vinogradova and colleagues’ study is a welcome addition to the literature on the association between hormone replacement therapy (HRT) and risk of venous thromboembolism.1 The results are broadly in keeping with other research in this area, but this study provides greater detail about the potential risks of different HRT preparations, including the different types of oestrogen and progestogens, …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription